In conclusion, we identified GULPsig, consisting of IGF2BP1, IGF2BP3, SMC1B, CLDN6, and LY6K, as a potential prognostic signature for lung adenocarcinoma patients. Here, IGF2BP1 is linked to lung adenocarcinoma.